欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6232/001
药品名称Fingolimod STADA 0,5 mg Hartkapseln
活性成分
    • fingolimod hydrochloride 0.56 mg
剂型Capsule, hard
上市许可持有人STADApharm GmbH Stadastr. 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Germany (DE)
Fingolimod STADA 0,5 mg Hartkapseln
互认成员国 - 产品名称
    • Greece (GR)
    • Denmark (DK)
    • Norway (NO)
    • Belgium (BE)
      Fingolimod EG 0,5 mg harde capsules
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Fingolimod STADA
    • Ireland (IE)
    • Austria (AT)
      Fingolimod STADA 0,5 mg Hartkapseln
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Fingolimod Stada
    • Hungary (HU)
    • Czechia (CZ)
      Fingolimod STADA
    • Slovakia (SK)
      Fingolimod STADA 0,5 mg tvrdé kapsuly
    • Slovenia (SI)
      Fingolimod STADA 0,5 mg trde kapsule
    • Croatia (HR)
      Fingolimod Stada 0,5 mg tvrde kapsule
    • Cyprus (CY)
      FINGOLIMOD/STADA 0.5MG CAPSULE, HARD
    • Lithuania (LT)
      Fingolimod STADA 0,5 mg kietosios kapsulės
    • Latvia (LV)
    • Estonia (EE)
许可日期2020/08/16
最近更新日期2024/10/21
药物ATC编码
    • L04AE01 fingolimod
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase